In The News,
ADVI CEO Marc Samuels On FDA Commissioner Gottlieb’s Comments Related to CAR-T Label Change
[el-text]
Written by Cathy Kelly
***excerpt***
A label change to allow for more outpatient use would allow for a “defined path which has fewer hurdles than the reimbursement path in the inpatient setting,” ADVI founder and CEO Marc Samuels said in an interview with the Pink Sheet.
***end excerpt***
***
[/el-text]